554 / 1068
3. HDR-EBT – Boost after EBRT
Late results (published in 2014)
- No benefit on late outcome
(OS, PFS, LC, distant mets)
- Improved tumor regression
does not lead to relevant
clinical benefit when high-
quality surgery is performed
Appelt et al. Int J Radiat Oncol Biol Phys. 2014;90(1):110–8.